The global polymerase chain reaction (PCR) market is experiencing strong growth, driven by increasing demand for advanced diagnostic techniques, expanding applications in genomics and molecular biology, and rising prevalence of infectious diseases. Valued at USD 10.1 billion in 2024, the market is projected to reach USD 24.0 billion by 2035, growing at a CAGR of 8.2% from 2025 to 2035. Continued advancements in PCR technologies, along with growing adoption in clinical diagnostics, research laboratories, and biotechnology industries, are key factors fueling market expansion.

👉 Get sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=830

Market Overview

Polymerase chain reaction (abbreviated PCR) is a laboratory technique for speedy production (amplification) of millions to billions of copies of a specific segment of DNA, which can then be studied in detail. PCR involves using short synthetic DNA fragments called primers to select a segment of the genome to be amplified, and then multiple rounds of DNA synthesis to amplify that segment.

Analysts’ Viewpoint on the PCR Market

Increase in PCR’s usage has allowed it to be a key part of the ongoing expansion of molecular diagnostics and biomedical research. The use of PCR for the identification of nucleic acids with a high level of specificity has made it a vital part of the testing for infectious diseases, genetic analysis of diseases, the study of cancer, and for the development of new treatments based on the characteristics of individual patients. The dependability and versatility of this technology have led to a continued and increasing demand for its use in clinical laboratories, other research institutions, and in the biotechnology sector.

In addition, the growth of the PCR market has also been supported by more advanced technologies now available in the market. Examples of advancements in PCR technology are real-time PCR, digital PCR, automation, and the use of high-throughput methods for the production of PCR products.

Analysis of Key Players in the PCR Market

The competitive landscape is defined by massive R&D investments and strategic acquisitions aimed at building “end-to-end” molecular ecosystems.

Leading companies operating in the global market include:

• Abbott
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• BioMérieux
• DiaSorin S.p.A.
• Meridian Bioscience, Inc.
• QIAGEN
• QuidelOrtho Corporation
• Siemens Healthineers AG
• Becton, Dickinson and Company (BD)
• Bruker
• Cosmos Biomedical Ltd.
• Agilent Technologies, Inc.
• PCR Biosystems Inc.
• Quantabio
• Promega Corporation
• Other Prominent Players

Recent Developments in PCR Technology

• In July 2025, Bio-Rad Laboratories, Inc. announced the launch of four new Droplet Digital PCR (ddPCR) platforms. The newly introduced instruments include Bio-Rad’s QX Continuum ddPCR system along with the QX700 series of ddPCR platforms acquired as part of the company’s recently completed acquisition of digital PCR developer Stilla Technologies
• In April 2025, Seegene Inc. started advancing its vision for innovation in laboratory automation with the development of CURECA a next-generation system currently under development, designed to streamline automation in polymerase chain reaction (PCR) testing and laboratory environments. The company announced that it will showcase a conceptual video introducing the CURECA system at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global 2025), held April 11-15 in Vienna, Austria
• In January 2025, QIAGEN announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more than two-fold increase in the number of targets that can be simultaneously analyzed from a single biological sample. The new capabilities overcome the assay design challenges of currently available quantitative multiplex PCR methods, making QIAcuity digital PCR ideal for applications such as translational research, microbiome analysis, pathogen detection and the development of cell and gene therapies

👉 Discuss Implications for Your Industry Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=830

Key Market Trends & Strategies

🧬 The Shift to Digital PCR (dPCR)

Unlike traditional qPCR, dPCR provides absolute quantification without needing a standard curve. This makes it the “gold standard” for 2026 in monitoring minimal residual disease (MRD) in cancer patients and quantifying low viral loads (e.g., HIV or Hepatitis).

📈 Market Challenges

• High Instrument Costs: Premium dPCR and high-throughput qPCR systems remain capital-intensive, which can limit adoption in resource-constrained regions.
• Competition from NGS: Next-Generation Sequencing (NGS) is becoming more competitive for broad genomic profiling, though PCR remains faster and more cost-effective for targeted testing.

🌟 Growth Opportunities

• Point-of-Care (POC) Integration: Developing battery-powered, handheld PCR devices for use in remote areas, disaster relief, and emergency rooms.
• Precision Oncology: Using PCR for rapid biomarker validation to determine patient eligibility for high-cost immunotherapy treatments.

Market Segmentation

• By Product Type
• Instruments
• Reagent and Consumables
• Software and Services
• By Technique
• Conventional PCR
• Real-Time PCR
• Reverse Transcriptase PCR
• Digital PCR
• Others (Multiplex PCR)
• By Application
• Clinical
• Pathogen Testing
• Oncology Testing
• Blood Screening
• Others
• Research
• Others
• By End-user
• Hospitals and Clinics
• Biotechnology and Pharmaceutical Companies
• Diagnostic Centers
• Others (Academic and Research Organization, etc.)

Regional Outlook

• North America: The largest market (~39% share in 2026). Driven by advanced healthcare infrastructure, high NIH funding, and a strong push for precision medicine.
• Asia-Pacific: The fastest-growing market. Growth is powered by massive laboratory upgrades in China and India, alongside expanding government initiatives for infectious disease control.
• Europe: A steady market focused on high-quality clinical diagnostics and the integration of the EU AI Act into digital molecular analysis workflows.

Conclusion

By 2026, the PCR market has successfully reinvented itself for a post-pandemic world. The technology is no longer confined to the central lab; it is becoming a modular, intelligent, and highly accessible tool for everything from community health surveillance to personalized cancer therapy. For industry leaders, the focus is now on “Absolute Accuracy”—delivering the sensitivity of Digital PCR at the speed and cost of a standard diagnostic test.

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=830&ltype=S

FAQs

• How big was the global polymerase chain reaction (PCR) market in 2024?

The polymerase chain reaction (PCR) market was valued at US$ 10.1 Bn in 2024

• What is the projected size of the polymerase chain reaction (PCR) Industry by 2035?

The polymerase chain reaction (PCR) market is projected to cross US$ 24.0 Bn by the end of 2035

• What are the factors driving the polymerase chain reaction (PCR) market?

Increasing demand for accurate and rapid molecular diagnostics and growing prevalence of infectious and genetic diseases

• What is the polymerase chain reaction (PCR) market expected to grow during the forecast period?

The polymerase chain reaction (PCR) market is anticipated to grow at a CAGR 8.2% from 2025 to 2035

• Which region is expected to dominate the polymerase chain reaction (PCR) market during the forecast period?

North America is expected to account for the largest share from 2025 to 2035

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com